Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

NCT06361329 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

ETP-ALL

Interventions

DRUG: Homoharringtonine
DRUG: venetoclax
DRUG: Cytarabine
DRUG: G-CSF
DRUG: Vindesine
DRUG: Daunorubicin
DRUG: cyclophosphamide
DRUG: Dexamethasone
DRUG: L-ASP

Sponsor

First Affiliated Hospital of Zhejiang University